Anti-IgE:IgE complexes may transform CAR T-cell treatment for refractory autoimmune diseases. By leveraging AI-assisted bioengineering strategies—including multi-specific “Triton” nanobodies, logic-gated encapsulation, structural conformance tuning, and co-delivery with tolerogenic peptides—this approach may enable loc...
M. Dochniak· GSC Advanced Research and Re...· 0 citations
Giant cell myocarditis (GCM) is a rare, rapidly progressive cardiac disorder characterized by giant, multinucleated cells that contribute to severe myocardial damage. Existing combination immunosuppressive therapies, although directed at immune-mediated injury, lack precision and are associated with considerable advers...
M. Dochniak· GSC Advanced Research and Re...· 0 citations
A strategy to enhance CAR T-cell therapy by integrating preformed anti-IgE:IgE complexes, particularly those using clone 8D6 antibody (and its humanized counterpart, UB-221) is highlighted, proposing a safer, more effective pathway for treating refractory autoimmune diseases.
M. Dochniak· GSC Advanced Research and Re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
